BWV News and Press, Blue Water Vaccines Inc. From 07/27/22

Blue Water Vaccines ( BWV ) +60% . Pzena Investment Management ( PZN ) +45% goes private at $795M valuation. Teva Pharmaceutical ( TEVA ) +24% Industries Limited 2022 Q2 - Results - Earnings Call Presentation. VNET Group ( VNET ) +14% . ...

Newly IPO’d biotech Blue Water Vaccines ( NASDAQ: BWV ) announced a sponsored research agreement with Cincinnati Children’s Hospital Medical Center on Wednesday to study vaccine candidate for conditions such as Alzheimer’s. The news sent company shares m...

CINCINNATI, July 20, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...

CINCINNATI, June 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...

CINCINNATI, May 31, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges , today anno...

Stocks had a ripsnorter of a rally last week and a lot of people are pondering the question in the title over this long weekend. Sentiment is certainly negative right now by several measures. Sentiment surveys (AAII, Investor’s Intelligence, etc.) are universally negative becau...

Blue Water Vaccines (NASDAQ:BWV) on Thursday said it is collaborating with Brazil's Instituto Butantan to develop Blue Water's universal influenza vaccine candidate, BWV-101. The collaboration is with the Center for R&D in Immunobiologics, a Butantan initiative. Butantan is the largest di...

CINCINNATI, May 19, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing vaccines, announces a collaboration with the multidisciplinary Center for R&D in Immu...

Blue Water Vaccines has a long road ahead of it. The company has multiple drug candidates in its pipeline but has not yet started clinical trials. Getting any particular vaccine through phase 3 trials will likely cost at least $40mm and take at least six years. On the positive...

Gainers: Applied UV (AUVI) +30%. Forge Global Holdings (FRGE) +29%. Jumia Technologies (JMIA) +27%. Sunlight Financial Holdings (SUNL) +26%. Blue Water Vaccines (BWV) +26%. Enthusiast Gaming Holdings (EGLX) +25%. BTCS (BTCS) +24%. Yellow (YELL) +22%. Marpai (MRAI) +21%. Losers: AutoWeb (AUTO)...